Testimony Opposing SB 2402: Texas Pharmaceutical Initiative

TAHP member plans are concerned that SB 2402 could create a carve-out of the prescription drug program from Medicaid managed care, returning Medicaid to a fragmented fee-for-service program. If this is not the intent, we respectfully request clarifying language be added to the legislation.

Multiple studies have shown that carving drugs out of managed care in Texas would cost Texas taxpayers hundreds of millions of dollars. Equally important, we are concerned that a carve-out would negatively impact health care outcomes by creating barriers that prevent Texas families from receiving the care coordination they need to stay in their communities and lead active lives.

View the full letter.

Become a Member

Membership with TAHP is an invaluable tool for integrating, building relationships, exchanging information and best practices, and promoting your services. You will be well-armed with the most timely and accurate information, strong relationships with key Texas leaders, and access to seasoned policy and regulatory experts.